Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells

被引:0
作者
Guizhen Wang
Qun Zhao
Hui Zhang
Fan Liang
Chen Zhang
Jun Wang
Zhenyin Chen
Ran Wu
Hong Yu
Beibei Sun
Hua Guo
Ruie Feng
Kaifeng Xu
Guangbiao Zhou
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[2] Chinese Academy of Sciences & University of Chinese Academy of Sciences,State Key Laboratory of Membrane Biology, Institute of Zoology
[3] Hubei University of Medicine,Department of Pathology, Peking Union Medical College Hospital
[4] Chinese Academy of Medical Sciences,Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital
[5] Chinese Academy of Medical Sciences,School of Chinese Materia Medica
[6] Guizhou University School of Medicine,undefined
[7] Beijing University of Chinese Medicine,undefined
来源
Frontiers of Medicine | 2021年 / 15卷
关键词
SARS-CoV-2; tobacco smoke; benzo(a)pyrene; ACE2; Skp2;
D O I
暂无
中图分类号
学科分类号
摘要
An unexpected observation among the COVID-19 pandemic is that smokers constituted only 1.4%–18.5% of hospitalized adults, calling for an urgent investigation to determine the role of smoking in SARS-CoV-2 infection. Here, we show that cigarette smoke extract (CSE) and carcinogen benzo(a)pyrene (BaP) increase ACE2 mRNA but trigger ACE2 protein catabolism. BaP induces an aryl hydrocarbon receptor (AhR)-dependent upregulation of the ubiquitin E3 ligase Skp2 for ACE2 ubiquitination. ACE2 in lung tissues of non-smokers is higher than in smokers, consistent with the findings that tobacco carcinogens downregulate ACE2 in mice. Tobacco carcinogens inhibit SARS-CoV-2 spike protein pseudovirions infection of the cells. Given that tobacco smoke accounts for 8 million deaths including 2.1 million cancer deaths annually and Skp2 is an oncoprotein, tobacco use should not be recommended and cessation plan should be prepared for smokers in COVID-19 pandemic.
引用
收藏
页码:252 / 263
页数:11
相关论文
共 252 条
[1]  
Lippi G(2020)Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) Eur J Intern Med 75 107-108
[2]  
Henry BM(2020)Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med 15 845-852
[3]  
Farsalinos K(2020)Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020 MMWR Morb Mortal Wkly Rep 69 382-386
[4]  
Barbouni A(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-1720
[5]  
Niaura R(2020)COVID-19 and smoking: a systematic review of the evidence Tob Induc Dis 18 20-252
[6]  
Guan WJ(2010)The transcriptome of Nrf2 Toxicol Sci 115 238-L963
[7]  
Ni ZY(2015) mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes eLife 4 e09419-70
[8]  
Hu Y(2003)The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution Am J Physiol Lung Cell Mol Physiol 284 L955-914
[9]  
Liang WH(2015)Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts Cancer Lett 363 60-280
[10]  
Ou CQ(2014)Tobacco smoke induces production of chemokine CCL20 to promote lung cancer Carcinogenesis 35 905-192